NIRAMAI Health Analytix Company
NIRAMAI has developed a novel breast cancer screening solution that uses Thermalytix.
Funding Status:
Early Stage Venture
Industry:
Data Processing
Estimated Revenue:
$1M to $10M
Technology:
Biomarkers of Female Cancers
Headquarters:
Bangalore, Karnataka, India
Total Funding:
6050000.0
Last Funding Date:
2021-06-29
Last Funding Type:
Grant
Employee Number:
43840
Investors Number:
9.0
Founded Date:
2016-01-01